Hines Nut Company, Dallas, TX, today announced a voluntary recall of WALNUT HALVES & PIECES, Lot Number 6989. The product was supplied by GOLD STATE NUT COMPANY of Biggs, CA, and packaged by Hines Nut Company. There is a possibility these nuts may be contaminated with Salmonella.
FDA approves first-of-its-kind corneal implant to improve near vision in certain patients
The U.S. Food and Drug Administration today approved the KAMRA inlay, a device implanted in the cornea of one eye (the clear, front surface) to improve near vision in certain patients with presbyopia. It is the first implantable device for correction of near vision in patients who have not had cataract surgery.
Conway Import Co., Inc. is Voluntarily Recalling Conway Organic Sesame Ginger Dressing and Conway Citrus Organic Vinaigrette Dressing Due to Possible Health Risk
Conway Import Co., Inc. is recalling Conway Organic Sesame Ginger Dressing and Conway Citrus Organic Vinaigrette Dressing because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain.
Schnucks Recalls Chef’s Express California Pasta Salad Because of Possible Health Risk
Schnuck Markets, Inc. of St. Louis, Mo. is recalling its Chef’s Express California Pasta Salad sold in its Deli/Chef’s Express departments April 2 – April 14, 2015 because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting in the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms, endocarditis and arthritis.
Smiths Food and Drug Stores recall In-store Bakery Carrot Cake
Smiths Food and Drug Stores said today it is recalling select Smiths Bakery Fresh Carrot Cake sold in 7 states because the product contains walnuts that may not be listed on the label.
FDA approves first generic Copaxone to treat multiple sclerosis
The U.S. Food and Drug Administration today approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with relapsing forms of multiple sclerosis (MS).
U.S. Marshals seize unapproved drugs from Florida distributor
At the request of the U.S. Food and Drug Administration and the U.S. Attorney for the Southern District of Florida, U.S. Marshals seized unapproved prescription drug products valued at over $1,500,000 from Stratus Pharmaceuticals, Inc., of Miami, Florida. Stratus Pharmaceuticals marketed and distributed unapproved prescription drug products that were manufactured by Sonar Products, Inc., of Carlstadt, New Jersey.
Solutions At Work, Inc. Issues Allergy Alert On Undeclared Raw Cashews In Cleveland Crops Chili Cheezy Kale Chips
Solutions At Work, Inc. of Cleveland, Ohio is recalling CLEVELAND CROPS CHILI CHEEZY KALE CHIPS because they may contain undeclared raw cashews. People who have an allergy or severe sensitivity to raw cashews run the risk of serious or life-threatening allergic reaction if they consume this product.
OriGen Biomedical Issues Nationwide Recall of OriGen VV13F Reinforced Dual Lumen ECMO Catheters
On March 30, 2015, OriGen Biomedical initiated a nationwide recall for one lot of 51 VV13F Reinforced Dual Lumen ECMO Catheters. These VV13F Reinforced Dual Lumen ECMO Catheters have been found to have the potential for a separation of the clear extension tube from the hub that it is inserted in, which potentially could result in required intervention to prevent permanent impairment/damage.
FDA approves Corlanor to treat heart failure
The U.S. Food and Drug Administration today approved Corlanor (ivabradine) to reduce hospitalization from worsening heart failure.